Folic acid supplementation and cardiovascular disease: The state of the art

American Journal of the Medical Sciences

Volumn 338, Issue 1, 2009, Pages 48-49

  Bazzano, Lydia A ^a,b  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Dietary supplements; Folic acid

Indexed keywords

CHOLESTEROL; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; HOMOCYSTEINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

AMINO ACID BLOOD LEVEL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CONGENITAL HEART DISEASE; DEMETHYLATION; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PRENATAL EXPOSURE; PROGENY; STROKE; SYSTOLIC BLOOD PRESSURE; VITAMIN SUPPLEMENTATION; ARTICLE; DIET SUPPLEMENTATION; FEMALE; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 68849095595     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181aaefd6     Document Type: Conference Paper

References (14)

1. Food and Drug Administration. Food labeling: Health claims and food label statements; folate and neural tube defects. Federal Register 1996;61:8752-8807
2. B-Vitamin Treatment Trialists' Collaboration. Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. Am Heart J 2006;151: 282-287
3. McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-128
4. Hajjar KA. Homocysteine: A sulph'rous fire. J Clin Invest 2001;107: 663-664
5. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002;288: 2015-2022
6. Kelly PJ, Rosand J, Kistler JP, et al. Homocysteine, MTHFR 677C-T polymorphism, and risk of ischemic stroke: Results of a meta-analysis. Neurology 2002;59:529-536
7. Klerk M, Verhoef P, Clarke R, et al. MTHFR 677C-T polymorphism and risk of coronary heart disease: A meta-analysis. JAMA 2002;288:2023-2031 (Pubitemid 35204693)
8. Lewis SJ, Ebrahim S, Davey Smith G. Meta-analysis of MTHFR 677C-T polymorphism and coronary heart disease: Does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ 2005;331:1053.
9. Bazzano LA, Reynolds K, Holder KN, et al. Effect of folic acid supplementation on risk of cardiovascular diseases: A meta-analysis of randomized controlled trials. JAMA 2006;296:2720-2726
10. Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet 2007;369:1876-1882
11. Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: A randomized trial. JAMA 2008;299:2027-2036
12. Ebbing M, Bleie O, Ueland PM, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: A randomized controlled trial. JAMA 2008;300: 795-804.
13. SEARCH Study Collaborative Group. SEARCH (Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine): Randomized comparison of folic acid 2 mg plus vitamin b12 1 mg daily versus placebo for 7 years in 12,064 myocardial infarction survivors. Circulation 2008;118:2310.
14. Van Beynum IM, den Heijer M, Blom HJ, et al. The MTHFR 677C-T polymorphism and the risk of congenital heart defects: A literature review and meta-analysis. QJM 2007;100:743-753